Published in Gastrointest Endosc on July 01, 2002
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci (2005) 1.63
Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J Gastroenterol (2004) 1.29
Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol (2010) 1.08
Diagnosis of cholangiocarcinoma. HPB (Oxford) (2008) 1.05
New insights on cholangiocarcinoma. World J Gastrointest Oncol (2010) 0.94
Increased serum levels of carbohydrate antigen 19-9 and outcomes in primary sclerosing cholangitis patients without cholangiocarcinoma. Dig Dis Sci (2012) 0.92
Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma. Int J Clin Exp Pathol (2014) 0.90
Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer. J Clin Exp Hepatol (2011) 0.89
Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol (2008) 0.88
Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci (2007) 0.87
Management of primary sclerosing cholangitis: conventions and controversies. Can J Gastroenterol (2012) 0.86
Malignancies in Primary Sclerosing Cholangitis - A Continuing Threat. Dig Dis (2015) 0.83
Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma. World J Gastroenterol (2005) 0.83
A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis. United European Gastroenterol J (2015) 0.80
Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Med Sci Monit (2015) 0.80
Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Therap Adv Gastroenterol (2015) 0.80
Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma. PLoS One (2014) 0.79
Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy. World J Gastrointest Endosc (2016) 0.78
Liver Transplantation for Cholestatic Liver Disease. Curr Treat Options Gastroenterol (2003) 0.78
CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test? Dig Dis Sci (2007) 0.75
Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer. World J Surg Oncol (2016) 0.75
Advanced endoscopic imaging of indeterminate biliary strictures. World J Gastrointest Endosc (2015) 0.75
Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis. Dig Dis Sci (2016) 0.75
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy. Cancer Res Treat (2017) 0.75
Management of an unclear bile duct stenosis. Surg Endosc (2004) 0.75
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Genomic variation landscape of the human gut microbiome. Nature (2012) 4.38
The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med (2008) 4.22
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology (2015) 3.96
Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med (2008) 3.94
Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol (2009) 3.88
Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA (2003) 3.82
Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol (2009) 3.59
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int (2008) 3.51
Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A (2011) 3.34
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16
Risk factors for complications after performance of ERCP. Gastrointest Endosc (2002) 2.93
A transcriptomic analysis of the phylum Nematoda. Nat Genet (2004) 2.68
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc (2005) 2.63
Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest Endosc (2009) 2.55
Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 2.46
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med (2007) 2.29
Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst (2005) 2.27
Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med (2009) 2.23
Analysis and functional classification of transcripts from the nematode Meloidogyne incognita. Genome Biol (2003) 2.10
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol (2013) 2.08
Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol (2009) 2.04
The draft genome of the parasitic nematode Trichinella spiralis. Nat Genet (2011) 2.03
Applying a natural language processing tool to electronic health records to assess performance on colonoscopy quality measures. Gastrointest Endosc (2012) 1.96
Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet (2003) 1.95
Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience. Gastrointest Endosc (2011) 1.95
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol (2005) 1.78
Informed decision-making and colorectal cancer screening: is it occurring in primary care? Med Care (2008) 1.75
Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database. Genome Res (2003) 1.75
Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records. Clin Ther (2002) 1.72
Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology (2012) 1.71
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg (2005) 1.70
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One (2010) 1.66
Pulmonary nodule detection with low-dose CT of the lung: agreement among radiologists. AJR Am J Roentgenol (2005) 1.66
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry (2008) 1.66
Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res (2002) 1.65
A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol (2012) 1.63
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) (2012) 1.63
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet (2012) 1.63
Endoscopic therapy is effective for patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2012) 1.63
A compilation of soybean ESTs: generation and analysis. Genome (2002) 1.62
Intestinal transplantation for the treatment of neoplastic disease. J Surg Oncol (2005) 1.62
The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol (2008) 1.61
Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. Gynecol Oncol (2002) 1.60
A knowledge-based clustering algorithm driven by Gene Ontology. J Biopharm Stat (2004) 1.59
Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol (2008) 1.58
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology (2005) 1.58
Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study. J Thorac Oncol (2011) 1.57
Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women. Cancer Epidemiol Biomarkers Prev (2002) 1.57
Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res (2005) 1.57
CDC-funded intervention research aimed at promoting colorectal cancer screening in communities. Cancer (2006) 1.57
Quality of patient referral information for open-access endoscopic procedures. Gastrointest Endosc (2006) 1.56
Improving selection criteria for lung cancer screening. The potential role of emphysema. Am J Respir Crit Care Med (2015) 1.55
Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc (2005) 1.54
Pancreaticobiliary complications after composite visceral transplantation: incidence, risk, and management strategies. Gastrointest Endosc (2011) 1.52
Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control (2010) 1.52
Retracted Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clin Cancer Res (2008) 1.51
Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap? Am J Gastroenterol (2011) 1.48
Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension (2011) 1.48
Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain. Dig Dis Sci (2005) 1.48
Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev (2006) 1.46
Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clin Gastroenterol Hepatol (2012) 1.44
PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J Clin Invest (2011) 1.43
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2008) 1.42
Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med (2009) 1.41
The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration. Lancet (2002) 1.41
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol (2007) 1.40
12-O-tetradecanoylphorbol-13-acetate (TPA)-induced dual-specificity phosphatase expression and AML cell survival. Leuk Res (2005) 1.40
MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study. Cancer Prev Res (Phila) (2012) 1.39
Developing a pathway for high-value, patient-centered total joint arthroplasty. Clin Orthop Relat Res (2013) 1.39
Endoscopic retrograde cholangiopancreatography is safe and effective for the diagnosis and treatment of pancreaticobiliary disease following abdominal organ transplant in children. Pediatr Transplant (2012) 1.39
Endoscopic clip application devices. Gastrointest Endosc (2006) 1.38
Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial. Am J Gastroenterol (2009) 1.38
Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr (2007) 1.37
100 multivisceral transplants at a single center. Ann Surg (2005) 1.34
Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol Chem (2007) 1.33
Endosymbiont DNA in endobacteria-free filarial nematodes indicates ancient horizontal genetic transfer. PLoS One (2010) 1.33
Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav Immun (2009) 1.31
Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis. Am J Gastroenterol (2009) 1.30
Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.30